Usana Health Sciences (USNA) Enterprise Value (2010 - 2026)

Usana Health Sciences (USNA) has reported Enterprise Value for 17 consecutive years, with $273.2 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Enterprise Value fell 42.07% year-over-year to $273.2 million in Q3 2026; TTM through Jul 2026 was $273.2 million, a 42.07% decrease from a year earlier, with the FY2026 full-year figure at $250.2 million, down 54.75% from the prior year.
• Enterprise Value was $273.2 million for Q3 2026 at Usana Health Sciences, up from $200.4 million in the prior quarter.
• Over five years, Enterprise Value peaked at $1.7 billion in Q1 2022 and troughed at $200.4 million in Q2 2026.
• A 5-year average of $693.6 million and a median of $595.4 million in 2024 frame the typical range for Enterprise Value.
• The widest YoY moves for Enterprise Value: up 31.5% in 2022, down 57.43% in 2022.
• Over 5 years, Enterprise Value stood at $733.3 million in 2022, then slipped by 5.24% to $694.9 million in 2023, then dropped by 20.45% to $552.8 million in 2024, then declined by 22.32% to $429.4 million in 2025, then slumped by 36.37% to $273.2 million in 2026.
• The last three Enterprise Value figures came in at $273.2 million (Q3 2026), $200.4 million (Q2 2026), and $250.2 million (Q1 2026), per Business Quant data.